High-risk Therapeutic Devices Approved by the US Food and Drug Administration for Use in Children and Adolescents From 2016 to 2021
Open Access
- 7 November 2022
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Pediatrics
- Vol. 177 (1) , 98-100
Abstract
Few medical devices are developed specifically for use in children, although pediatric patients have unique requirements related to device indication and function. Thus, physicians often repurpose or modify devices designed for adults to meet pediatric needs.1 In most cases, data on safety and effectiveness for these off-label applications are lacking.2 Congress and the US Food and Drug Administration (FDA) have introduced several legislative and regulatory strategies, including the Pediatric Medical Device Safety and Improvement Act (passed in 2007), to expand pediatric-specific medical device development.3,4 The aim of this study was to evaluate and compare characteristics and premarket and postmarket clinical evidence for FDA-approved high-risk therapeutic devices for pediatric and adult populations.Keywords
This publication has 4 references indexed in Scilit:
- Pediatric Medical Device Development and Regulation: Current State, Barriers, and OpportunitiesPediatrics, 2022
- Postmarketing Trials and Pediatric Device ApprovalsPediatrics, 2014
- Pediatric Interventional Cardiology in the United States is Dependent on the Off-label Use of Medical DevicesCongenital Heart Disease, 2010
- Pathways to Approval of Pediatric Cardiac Devices in the United States: Challenges and SolutionsPediatrics, 2009